证券研究报告 氧氮价格拐点向上，液氧连续三周同比正增长 ——工业气体跟踪（6月） 行业评级：看好 2025年7月7日 | 分析师 | 邱世梁 | 分析师 | 王华君 | 分析师 | 李思扬 | | --- | --- | --- | --- | --- | --- | | 证书编号 | S1230520050001 | 证书编号 | S1230520080005 | 证书编号 | S1230522020001 | | 邮箱 | qiushiliang@stocke.com.cn | 邮箱 | wanghuajun@stocke.com.cn | 研究助理 | 张筱晗 | 工业气体：氧氮价格拐点向上，液氧连续三周同比正增长 ➢ 空分气价止跌回稳：6月，液氧/液氮/液氩均价位于历史28%/25%/10%分位值 2 1、中国工业气体行业近2000亿元市场，过去5年复合增速超过10%； 2、行业整合预期，龙头份额提升，竞争格局改善； 3、海外可比公司林德气体市值超万亿元； ➢ 电子气体：全球半导体景气逐步复苏；电子气体行业有望持续受益 1、半导体行业复苏进程中，电子气体是重要耗材； 2、自主可控，国产替代加速； 3、 ...

| 证券代码：688106 | | --- | 证券代码：688106 证券简称：金宏气体 公告编号：2025-029 转债代码：118038 转债简称：金宏转债 金宏气体股份有限公司 关于增加募投项目实施主体并使用部分募集资金向 新增实施主体提供借款以实施募投项目的公告 二、募集资金投资项目情况 截至2024年12月31日，公司本次可转换公司债券募集资金投资项目募集资金 使用情况如下： 单位：万元 | | 项目投资 | 拟使用募 | 截至2024年12 | 投入进度 | | --- | --- | --- | --- | --- | | 序号 | 项目名称 | | 月31日已投入 | | | | 总额 | 集资金额 | | （%） | | | | | 募集资金金额 | | 新建高端电子专用材料 项目 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 金宏气体股份有限公司（以下简称"金宏气体"或"公司"）于2025年5月 于增加募投项目实施主体并使用部分募集资金向新增实施主体提供借款以实施 募投项目的议案》，同意公司新增全资 ...

Investment Rating - The report maintains an "Outperform" rating for the basic chemical industry [2]. Core Viewpoints - The commercialization of humanoid robots is accelerating, with a focus on four major investment themes related to the chemical sector. In Q1 2025, over 35 companies launched new humanoid robot products, with more than 21 from China. The market for humanoid robots is expected to reach 8.239 billion yuan, accounting for about 50% of the global market by 2025 [5][28]. Summary by Sections Market Performance - The basic chemical industry index increased by 2.7% from April 18 to April 25, outperforming the Shanghai Composite Index by 2.1 percentage points and the ChiNext Index by 1.0 percentage points. Year-to-date, the basic chemical industry index has risen by 1.7%, surpassing the Shanghai Composite Index by 3.4 percentage points and the ChiNext Index by 10.8 percentage points [3][16]. Investment Themes 1. **Equity Investment Strategy**: The humanoid robot industry is projected to produce over 10,000 units by 2025, with significant market potential. Chemical companies can enhance their technological attributes through early-stage equity investments [5][28]. 2. **Polymer Materials**: Humanoid robots require various polymer materials, with modified plastics being a key solution for lightweight components. The demand for PEEK is expected to grow significantly, with a projected CAGR of 16.8% from 2022 to 2027 [5][29]. 3. **Tendon Materials**: Tendon systems are crucial for humanoid robots, with UHMWPE and carbon fiber being ideal materials due to their superior properties. Companies like Tongyi Zhong and Nanshan Zhishang are leading in UHMWPE production [5][6]. 4. **Electronic Skin Materials**: The electronic skin market is expected to grow from 6.3 billion USD in 2024 to 30 billion USD by 2034, with companies like Fulei New Materials and Hanwei Technology actively developing flexible sensor materials [5][6]. Product Price Changes - The report lists significant price changes for chemical products, with the top gainers including glyphosate (+16.3%) and liquid nitrogen (+13.7%). Conversely, coal tar saw a decline of 11.8% [5]. Investment Recommendations - Core assets in the chemical sector are entering a long-term value zone, with companies like Baofeng Energy and Wanhua Chemical recommended for investment. Additionally, sectors facing supply constraints, such as vitamins and refrigerants, are highlighted for their potential price elasticity [5][14][15].

Investment Rating - The report maintains an "Outperform" rating for the basic chemical industry [2]. Core Viewpoints - The commercialization of humanoid robots is accelerating, with a focus on four major investment themes related to the chemical sector. In Q1 2025, over 35 companies launched new humanoid robot products, with more than 21 from China. The market for humanoid robots is expected to reach 8.239 billion yuan, accounting for about 50% of the global market by 2025 [5][28]. Summary by Sections Market Performance - The basic chemical industry index increased by 2.7% from April 18 to April 25, outperforming the Shanghai Composite Index by 2.1 percentage points and the ChiNext Index by 1.0 percentage points. Year-to-date, the basic chemical industry index has risen by 1.7%, surpassing the Shanghai Composite Index by 3.4 percentage points and the ChiNext Index by 10.8 percentage points [3][16]. Investment Themes 1. **Equity Investment Strategy**: The humanoid robot industry is projected to produce over 10,000 units by 2025, with significant market potential. Chemical companies can enhance their technological attributes through early-stage equity investments [5][28]. 2. **Polymer Materials**: Humanoid robots require various polymer materials, with modified plastics being a key solution for lightweight components. The demand for PEEK is expected to grow significantly, with a projected CAGR of 16.8% from 2022 to 2027 [5][29]. 3. **Tendon Materials**: Tendon systems are crucial for humanoid robots, with UHMWPE and carbon fiber being ideal materials due to their superior properties. Companies like Tongyi Zhong and Nanshan Zhishang are leading in UHMWPE production [6][29]. 4. **Electronic Skin Materials**: The electronic skin market is expected to grow from 6.3 billion USD in 2024 to 30 billion USD by 2034, with companies like Fulei New Materials and Hanwei Technology actively developing flexible sensor materials [5][29]. Product Price Changes - The report lists significant price changes for chemical products, with the top gainers including glyphosate (+16.3%) and liquid nitrogen (+13.7%). Conversely, coal tar saw a decline of 11.8% [5][6]. Investment Recommendations - Core assets in the chemical sector are entering a long-term value zone, with companies like Baofeng Energy and Wanhua Chemical recommended for investment. Additionally, sectors facing supply constraints, such as vitamins and refrigerants, are highlighted for their potential price elasticity [5][14].

证券代码：600955 证券简称：维远股份 公告编号：2025-010 利华益维远化学股份有限公司 2024年度主要经营数据公告 本公司及董事会全体成员保证本公告内容不存在虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露： 第十三号——化工》的相关要求，利华益维远化学股份有限公司（以下简 称"公司"）现将 2024 年度主要经营数据披露如下： 注：1、酚酮相关产品主要包括：苯酚、丙酮、异丙醇、双酚 A。 2、新能源新材料相关产品主要包括：碳酸二甲酯、碳酸丙烯酯、聚碳酸酯、聚碳酸酯改性 合金等产品。 3、专用化学品主要包括：丙烯、环氧丙烷、双氧水、碳四、丙二醇等。 4、工业气体主要包括：氢气、氮气、氧气、仪表空气、二氧化碳、液氧、液氮、液氩等。 二、主要产品及原材料的价格变动情况 （一）主要产品的价格变动情况（不含税） 1 主要产品 2024 年度产量（吨） 2024 年度外销量 （吨） 2024 年度销售金额 （不含税）（万元） 酚酮相关产 品 1,167,532.87 640,843.01 449,56 ...